RNAi-based nanomedicines for targeted personalized therapy.

  title={RNAi-based nanomedicines for targeted personalized therapy.},
  author={Ala Daka and Dan Peer},
  journal={Advanced drug delivery reviews},
  volume={64 13},
RNA interference (RNAi) has just made it through the pipeline to clinical trials. However, in order for RNAi to serve as an ideal personalized therapeutics and be clinically approved-safe, specific, and potent strategies must be devised for efficient delivery of RNAi payloads to specific cell types, which despite the immense potential, remains a challenge. Through evaluating the recent reported studies in this field, we introduce the progress in designing targeted nano-scaled strategies that… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS